Reminder systems, not education, improve glaucoma adherence: a comment on Cook et al
- PMID: 25212508
- PMCID: PMC6422341
- DOI: 10.1007/s12160-014-9644-5
Reminder systems, not education, improve glaucoma adherence: a comment on Cook et al
Conflict of interest statement
Author Harry Quigley declares that he has no conflict of interest. He is a consultant for 3 companies that make ophthalmic products or drugs (Zeiss, AC Immune, Sensimed) and is on the scientific advisory board of Graybug, Inc.
Comment on
-
Predictors of adherence to glaucoma treatment in a multisite study.Ann Behav Med. 2015 Feb;49(1):29-39. doi: 10.1007/s12160-014-9641-8. Ann Behav Med. 2015. PMID: 25248302 Free PMC article.
References
-
- Friedman DS, Jampel H, Congdon N, Miller R, Quigley HA. The TRAVATAN Dosing Aid accurately records when drops are taken. Am J Ophthalmol. 2007;143:699–701. - PubMed
-
- Okeke CO, Quigley HA, Jampel HD, Ying GS, Plyler RJ, Jiang Y, Friedman DS. Adherence with topical glaucoma medication monitored electronically: The Travatan Dosing Aid Study. Ophthalmology 2009;116:191–9. - PubMed
-
- Friedman DS, Quigley HA, Gelb L, Tan J, Margolis J, Shah SN, Kim EE, Zimmerman T, Hahn SR. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS). Invest Ophthalmol Vis Sci. 2007;48:5052–7. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical